Addressing Unmet Needs for Cholangiocarcinoma & Myeloid Lymphoid Neoplasms
Great Debate: Neoadjuvant vs. Adjuvant Therapy for High-Risk BTC - Pro Neoadjuvant
For more accreditation information, please visit https://integrityce.com/HopkinsGI2023
Login to view comments.
Click here to Login